According to the latest report published by Credence Research, Inc., the global intragastric balloon market was valued at US$ 120 million in 2015 and is expected to reach US$ 248 million by 2025, increasing to CAGR by 7.6 per cent from 2017 to 2025.

Market Insights

Intragastric balloons are devices made of biocompatible silicon and are placed inside the stomach to reduce the capacity. Compressed balloons are placed in the stomach through a non-invasive endoscopic procedure that is filled with saline, which means that the patient feels fuller and fuller sooner and longer and makes less room for food. These balloons can be removed once they are no longer required due to the risk of rupture after 6 to 7 months.

Browse Full Report Originally Published by Credence Research at https://www.credenceresearch.com/report/intragastric-balloons-market

In 2015, according to the OECD data, 19.5% of the adult population was obese. For adults, WHO defines that obesity is a body mass index (BMI) greater than or equal to 30 and most of such population is from emerging countries. This phenomenon can boost the demand for obesity treatments. With advancement in technology and availability of better treatments for obesity, and speedy increase in obese and overweight population, the demand for safer and temporary treatment solutions such as non-invasive endoscopic intragastric balloons treatment is set to grow. Upward trend in the growth rate of the overweight and obese population in adults and children reveals the powerful influence on the market. Moreover, advancement in technology, and regulatory aspects of the market are further enhancing the intragastric balloons market. In 2011-2014, according to the CDC data, the prevalence of obesity was 36% among U.S. adults and 17% in youth. Growing incidence rate of obesity among adults and young age is one of the main factor boosting the market growth.

On the basis of application areas, the global market of intragastric balloons is segmented into single balloons, double balloons, and triple balloons. Advancement in technology and growing incidence of obesity in adults, better patience consciousness and increase in disposable income in the emerging countries would further boost the acceptance of intragastric balloons.

Geographically, the global intragastric balloons market is studied for North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America currently leads the global market in terms of revenue share and it is expected that the region will retain its dominance during the forecast period. However, the dominance of North America will be prominently challenged by Europe and Asia Pacific market. The demand for advanced treatment for obesity has exponentially increased in Asia Pacific due to growth in healthcare expenditure, disposable income and rapid proliferation of healthcare infrastructure. Furthermore, countries such as Brazil, Mexico, China, and India will open additional opportunities for market penetration to key companies already having a stronghold in developed regions.

Some of the main players in the global intragastric balloons market are listed: Apollo Endosurgery, Allurion Technologies, Lexal Srl, Districlass Medical SA, Life Partners Europe, Fengh Medical, Medsil, Obalon Therapeutics, Phagia Technologies, PlenSat, ReShape Medical, Silimed, Spatz FGIA Inc, and Tulip Medical.

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/58845

Table of Content

Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Intragastric Balloons Market Portraiture
2.1.1. Global Intragastric Balloons Market, by Product, 2016 (US$ Mn)
2.1.2. Global Intragastric Balloons Market, by Usage Area, 2016 (US$ Mn)
2.1.3. Global Intragastric Balloons Market, by Geography, 2016 (US$ Mn)

Chapter 3. Intragastric Balloons: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.4.1. Attractive Investment Proposition, by Geography, 2016
3.5. Value Chain Analysis
3.6. Porter’s Five Forces Model
3.7. Competitive Landscape
3.7.1. Competitive Landscape, by Key Players, 2016

Chapter 4. Global Intragastric Balloons Market, by Product, 2015 – 2025 (US$ Mn)
4.1. Overview
4.2. Attractive Investment Proposition, by Product, 2016
4.3. Single Balloons
4.4. Double Balloons
4.5. Triple Balloons

Chapter 5. Global Intragastric Balloons Market, by Usage Area, 2015 – 2025 (US$ Mn)
5.1. Overview
5.2. Attractive Investment Proposition, by Usage Area, 2016
5.3. Hospitals
5.4. Ambulatory Centers
5.5. Private Clinics

Chapter 6. Global Intragastric Balloons Market, by Geography, 2015 – 2025 (US$ Mn)
…………………..

You can get the sample copy of this research by Credence Research here: https://www.credenceresearch.com/sample-request/58845

About Credence Research (Original Publisher)

Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.

Media Contact

Name: Chris Smith

Address: 105 N 1st ST #429,

SAN JOSE, CA 95103 US

Toll-Free (US/CANADA) Ph.: +1-800-361-8290

E-mail: [email protected]

Website: http://www.credenceresearch.com